Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Genet Med. 2019 Dec 11;22(4):727–735. doi: 10.1038/s41436-019-0702-z

Table 2.

Variable distributions: results from the analysis of primary and secondary outcomes

Decision aid (n = 68)
Mean (SD)
Genetic counselor (n = 65)
Mean (SD)
Intervention vs. control Between group difference
(95% CI)
Significance
Baseline After DA (T1) After DA + GC (T2) Baseline After GC (T1) T1 vs. T1 T2 vs. T1 T1 vs. T1 T2 vs. T1
Decisional conflict (1–5) 1.87 (0.71) 1.77 (0.69) 1.71 (0.54) 0.15 (−0.06 to 0.36) 0.05 (−0.15 to 0.27) 0.16 0.60
Decisional conflict adjusted score (0–100) 21.67 (17.77) 19.25 (17.16) 17.84 (13.51) −3.83 (−9.23 to 1.57) −1.41 (−6.75 to 3.93) 0.16 0.60
Knowledge of secondary findings (0–5) 4.92 (0.32) 4.93 (0.26) 4.54 (0.81) 0.39 (0.18 to 0.59) <0.001
Knowledge: sequencing limitations (1–10) 5.85 (2.53) 7.32 (2.53) 7.41 (2.46) 5.75 (2.74) 7.14 (2.74) 0.12 (−0.67 to 0.86) 0.14 (−0.61 to 0.89) 0.73 0.70
Knowledge: sequencing benefits (1–10) 5.12 (2.00) 7.07 (2.19) 7.06 (2.12) 5.08 (1.97) 6.09 (2.47) 1.00 (0.26 to 174) 0.97 (0.22 to 0.95) 0.01 0.01
Preparation for decision-making (0–100) 74.38 (17.46) 76.06 (16.74) 76.23 (18.44) 1.86 (−4.31 to 8.02) 0.17 (−5.92 to 6.26) 0.55 0.95
Satisfaction with decision (6–30) 21.79 (7.95) 24.55 (5.54) 22.37 (7.71) 0.58 (−2.11 to 3.26) −2.18 (−4.5 to 0.15) 0.60 0.06
State-Trait Anxiety Inventory (20–80) 28.97 (11.16) 27.90 (9.72) 26.06 (9.14) 31.02 (12.45) 27.03 (9.64) 2.22 (−0.34 to 4.79) 0.72 (−1.73 to 3.18) 0.89 0.56
Time with genetic counselor (minutes) 16.15 (9.20) 40.55 (9.11) 24.40 (27.72 to −21.07) <0.001

CI confidence interval, DA decision aid, GC genetic counseling.